Mark Moore PhD

Mark Moore PhD

Company: GemPharmatech

Job title: CEO


Accelerating Antibody Research Using Humanized Mouse Models 3:50 pm

Humanized components of the immune/oncology checkpoint pathways Models for bi-specific antibody development Next generation immunodeficient mice (NCG) for xenografts and better stem cell engraftmentRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.